Canfite earnings
WebApr 10, 2024 · PETACH TIKVA, Israel,, April 10, 2024--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ... Web© 2024 Can-Fite All Rights Reserved. BrandWiz - Branding - Branding
Canfite earnings
Did you know?
WebApr 10, 2024 · View differences made from one to another to evaluate Canfite Biopharma Ltd.'s financial trajectory Sample 10-K Year-over-Year (YoY) Comparison Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Canfite Biopharma Ltd.. WebDec 31, 2024 · Can-Fite BioPharma Ltd. meldete die Ergebnisse für das am 31. Dezember 2024 endende Geschäftsjahr. Für das Gesamtjahr meldete das Unternehmen einen Umsatz von 0,81 Mio. USD, verglichen mit 0,853 Mio.... 12 April 2024
WebApr 10, 2024 · -- Can-Fite Biopharma Ltd teilte am Montag mit, dass es vom Ausschuss für Humanarzneimittel der Europäischen Arzneimittelagentur eine positive Stellungnahme zu seinem Zulassungsplan für eine... 11 April 2024 WebNext Earnings Date: The next reported earnings date. Stocks whose Next Earnings Date falls within the next 7 days are highlighted in red. Annual Dividend & Yield: The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar ...
WebMar 30, 2024 · Can-Fite BioPharma Ltd. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.81 million compared to USD 0.853 million a year ago. Net loss was USD 10.17 million compared to USD 12.62 million a year ago. WebCan-Fite BioPharma Ltd. Stock Earnings. The value each CANF share was expected to gain vs. the value that each CANF share actually gained. (CANF) reported earnings per share (EPS) of $0, — estimates of $0 by —.In the same quarter last year, 's earnings per share (EPS) was $0. is expected to release next earnings on -, with an earnings per …
WebFind real-time CANF - Can Fite Biopharma Ltd stock quotes, company profile, news and forecasts from CNN Business.
WebApr 6, 2024 · Can-Fite BioPharma Ltd. (CANF) latest earnings report: revenue, EPS, surprise, history, news and analysis. sokeefe fanfiction.netWebDec 31, 2024 · Can-Fite BioPharma Ltd. meldete die Ergebnisse für das am 31. Dezember 2024 endende Geschäftsjahr. Für das Gesamtjahr meldete das Unternehmen einen Umsatz von 0,81 Mio. USD, verglichen mit 0,853 Mio.... 11 April 2024 sluggish scrollingWebApr 6, 2024 · A high-level overview of Can-Fite BioPharma Ltd. (CANF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … soke clinic londonWebCan-Fite Biopharma Ltd. ADR analyst ratings, historical stock prices, earnings estimates & actuals. CANF updated stock price target summary. sokeefe fanfiction kotlcWebFor their last quarter, CanFite Biopharma (CANF) reported earnings of -$0.90 per share, beating the Zacks Consensus Estimate of $-1.00 per share. This reflects a positive earnings surprise of 10.00%. sluggish selecting vertices blenderWebApr 6, 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Can-Fite BioPharma stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for CANF. The average twelve-month price prediction for Can-Fite BioPharma is $34.00 with a high price target of $34.00 and a low price target of $34.00. sokeefe kiss fanfictionWebEdit. Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. sokeefe fanfiction stories kotlc